Insider trades
Daniel Faga, CEO of First Tracks Biotherapeutics TRAX, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $2.8M. The latest trade was on 05/12.
Daniel Faga
President, CEO
- First filing
- 23/01/10
- Trades
- 69 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$2.8M
- Last trade
- 05/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANAB | Open-market sale | 03/27 | 03/27 | 17,679 sh10 trades | $61.61avg. | $1,089,221.59 | −3.4% |
AnaptysbioANAB | Open-market sale | 01/08 | 01/09 | 14,281 sh | $44.71 | $638,503.51 | −2.9% |
AnaptysbioANAB | Open-market sale | 01/07 | 01/08 | 9,202 sh | $45.11 | $415,102.22 | −1.9% |
AnaptysbioANAB | Open-market sale | 01/05 | 01/06 | 15,309 sh | $43.26 | $662,267.34 | −3.2% |
ANAB | Open-market sale | 24/03/22–24/03/25 | 24/03/26 | 148,940 sh2 trades | $22.75avg. | $3,388,773.2 | −16.6% |
AnaptysbioANAB | Open-market sale | 24/01/08 | 24/01/09 | 6,866 sh | $21.81 | $149,747.46 | −0.8% |
